Proteins associated with cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels

Molecular and Cellular Proteomics

Volumn 5, Issue 3, 2006, Pages 433-443

  Stewart, Jennifer J ^a   White, James T ^a   Yan, Xiaowei ^a   Collins, Steven ^b   Drescher, Charles W ^b   Urban, Nicole D ^b   Hood, Leroy ^a   Lin, Biaoyang ^a,c  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Shanghai Jiao Tong University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CELL PROTEIN; CISPLATIN; CLAUDIN 4; MESSENGER RNA; PROTEIN CDC42; PROTEIN KINASE; PROTEIN S 100; PROTEOME; SCATTER FACTOR;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER RECURRENCE; CELL FRACTIONATION; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; DRUG RESPONSE; DRUG SENSITIVITY; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; MICROSOME; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TRANSCRIPTION REGULATION;

EID: 33645463240     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M500140-MCP200     Document Type: Article

References (37)

1. Hall, M. D., Amjadi, S., Zhang, M., Beale, P. J., and Hambley, T. W. (2004) The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines. J. Inorg. Biochem. 98, 1614-1624
2. Vasey, P. A. (2003) Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies. Br. J. Cancer 89, S23-S28
3. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994-999
4. Brenner, S., Johnson, M., Bridgham, J., Golda, G., Lloyd, D. H., Johnson, D., Luo, S., McCurdy, S., Foy, M., Ewan, M., Roth, R., George, D., Eletr, S., Albrecht, G., Vermaas, E., Williams, S. R., Moon, K., Burcham, T., Pallas, M., DuBridge, R. B., Kirchner, J., Fearon, K., Mao, J., and Corcoran, K. (2000) Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat. Biotechnol. 18, 630-634
5. Benard, J., Da Silva, J., De Blois, M. C., Boyer, P., Duvillard, P., Chiric, E., and Riou, G. (1985) Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res. 45, 4970-4979
6. Han, D. K., Eng, J., Zhou, H., and Aebersold, R. (2001) Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat. Biotechnol. 19, 946-951
7. Yi, E. C., Lee, H., Aebersold, R., and Goodlett, D. R. (2003) A microcapillary trap cartridge-microcapillary high-performance liquid chromatography electrospray ionization emitter device capable of peptide tandem mass spectrometry at the attomole level on an ion trap mass spectrometer with automated routine operation. Rapid Commun. Mass Spectrom. 17, 2093-2098
8. Eng, J., McCormack, A., and Yates, J. (1994) An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5, 976-989
9. Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392
10. Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658
11. Li, X. J., Zhang, H., Ranish, J. A., and Aebersold, R. (2003) Automated statistical analysis of protein abundance ratios from data generated by stable-isotope dilution and tandem mass spectrometry. Anal. Chem. 75, 6648-6657
12. Zeeberg, B. R., Feng, W., Wang, G., Wang, M. D., Fojo, A. T., Sunshine, M., Narasimhan, S., Kane, D. W., Reinhold, W. C., Lababidi, S., Bussey, K. J., Riss, J., Barrett, J. C., and Weinstein, J. N. (2003) GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol. 4, R28
13. Fujimoto, J., Ichigo, S., Hirose, R., Sakaguchi, H., and Tamaya, T. (1997) Expression of E-cadherin and α- and β-catenin mRNAs in ovarian cancers. Cancer Lett. 115, 207-212
14. Nur-E-Kamal, M. S., Kamal, J. M., Qureshi, M. M., and Maruta, H. (1999) The CDC42-specific inhibitor derived from ACK-1 blocks v-Ha-Ras-induced transformation. Oncogene 18, 7787-7793
15. Wang, X. S., Diener, K., Tan, T. H., and Yao, Z. (1998) MAPKKK6, a novel mitogen-activated protein kinase kinase kinase, that associates with MAPKKK5. Biochem. Biophys. Res. Commun. 253, 33-37
16. Hida, T., Ariyoshi, Y., Kuwabara, M., Sugiura, T., Takahashi, T., Hosoda, K., Niitsu, Y., and Ueda, R. (1993) Glutathione S-transferase levels in a panel of lung cancer cell lines and its relation to chemo-radiosensitivity. Jpn. J. Clin. Oncol. 23, 14-19
17. Cho, R. J., and Campbell, M. J. (2000) Transcription, genomes, function. Trends Genet. 16, 409-415
18. Boulikas, T., and Vougiouka, M. (2003) Cisplatin and platinum drugs at the molecular level. Oncol. Rep. 10, 1663-1682
19. Shridhar, V., Bible, K. C., Staub, J., Avula, R., Lee, Y. K., Kalli, K., Huang, H., Hartmann, L. C., Kaufmann, S. H., and Smith, D. I. (2001) Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer. Cancer Res. 61, 4258-4265
20. Siddik, Z. H. (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22, 7265-7279
21. Ormerod, M. G., O'Neill, C., Robertson, D., Kelland, L. R., and Harrap, K. R. (1996) cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines. Cancer Chemother. Pharmacol. 37, 463-471
22. Wang, X., Zhou, Y., Kim, H. P., Song, R., Zarnegar, R., Ryter, S. W., and Choi, A. M. (2004) Hepatocyte growth factor protects against hypoxia/reoxygenation-induced apoptosis in endothelial cells. J. Biol. Chem. 279, 5237-5243
23. Missotten, M., Nichols, A., Rieger, K., and Sadoul, R. (1999) Alix, a novel mouse protein undergoing calcium-dependent interaction with the apoptosis-linked-gene 2 (ALG-2) protein. Cell Death Differ. 6, 124-129
24. Chatellard-Causse, C., Blot, B., Cristina, N., Torch, S., Missotten, M., and Sadoul, R. (2002) Alix (ALG-2-interacting protein X), a protein involved in apoptosis, binds to endophilins and induces cytoplasmic vacuolization. J. Biol. Chem. 277, 29108-29115
25. Jansen, B. A., Brouwer, J., and Reedijk, J. (2002) Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs. J. Inorg. Biochem. 89, 197-202
26. 15N nuclear magnetic resonance. Cancer Chemother. Pharmacol. 37, 518-524
27. Shi, T., Dong, F., Liou, L. S., Duan, Z. H., Novick, A. C., and DiDonato, J. A. (2004) Differential protein profiling in renal-cell carcinoma. Mol. Carcinog. 40, 47-61
28. Zimmermann, U., Balabanov, S., Giebel, J., Teller, S., Junker, H., Schmoll, D., Protzel, C., Scharf, C., Kleist, B., and Walther, R. (2004) Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination. Cancer Lett. 209, 111-118
29. Han, E. K., Tahir, S. K., Cherian, S. P., Collins, N., and Ng, S. C. (2000) Modulation of paclitaxel resistance by annexin IV in human cancer cell lines. Br. J. Cancer 83, 83-88
30. Gonzalez-Mariscal, L., Betanzos, A., Nava, P., and Jaramillo, B. E. (2003) Tight junction proteins. Prog. Biophys. Mol. Biol. 81, 1-44
31. Li, D., and Mrsny, R. J. (2000) Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin. J. Cell Biol. 148, 791-800
32. Soler, A. P., Miller, R. D., Laughlin, K. V., Carp, N. Z., Klurfeld, D. M., and Mullin, J. M. (1999) Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20, 1425-1431
33. Hibbs, K., Skubitz, K. M., Pambuccian, S. E., Casey, R. C., Burleson, K. M., Oegema, T. R., Jr., Thiele, J. J., Grindle, S. M., Bliss, R. L., and Skubitz, A. P. (2004) Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am. J. Pathol. 165, 397-414
34. Rangel, L. B., Agarwal, R., D'Souza, T., Pizer, E. S., Alo, P. L., Lancaster, W. D., Gregoire, L., Schwartz, D. R., Cho, K. R., and Morin, P. J. (2003) Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin. Cancer Res. 9, 2567-2575
35. Long, H., Crean, C. D., Lee, W. H., Cummings, O. W., and Gabig, T. G. (2001) Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res. 61, 7878-7881
36. Tokes, A. M., Kulka, J., Paku, S., Szik, A., Paska, C., Novak, P. K., Szilak, L., Kiss, A., Bogi, K., and Schaff, Z. (2005) Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res. 7, R296-R305
37. Lee, S. K., Moon, J., Park, S. W., Song, S. Y., Chung, J. B., and Kang, J. K. (2005) Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma. Oncol. Rep. 13, 193-199